Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TARS | AZN | AMGN | GILD | BMY |
| Company | Tarsus Pharmaceuticals Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 72.72 | 207.30 | 357.46 | 142.38 | 59.79 |
| High | 73.33 | 207.30 | 357.46 | 142.38 | 59.80 |
| Low | 71.52 | 203.82 | 349.75 | 138.45 | 58.46 |
| Latest | 72.56 | 204.03 | 351.02 | 138.99 | 58.62 |
| Change | +0.13 | -0.96 | -4.58 | -3.10 | -0.85 |
| % Change | +0.19% | -0.47% | -1.29% | -2.18% | -1.43% |
| Volume | 383,800 | 1,565,700 | 2,258,000 | 4,418,800 | 8,060,000 |
| 20-Day Average Volume | 460,240 | 1,865,165 | 2,743,200 | 5,905,130 | 13,360,250 |
| Previous Close | 72.43 | 204.99 | 355.60 | 142.09 | 59.47 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 68.35 | 193.76 | 351.90 | 139.82 | 59.04 |
| 20-Day Raw Stochastic | 93.45% | 86.87% | 42.09% | 35.59% | 37.58% |
| 20-Day Relative Strength | 55.69 | 59.21 | 47.06 | 47.01 | 48.74 |
| Weighted Alpha | +53.63 | +53.08 | +23.44 | +33.17 | +21.67 |
| Today's Opinion | 24% Buy | 88% Buy | 40% Buy | 40% Buy | 48% Buy |
| Previous Opinion | 16% Buy | 88% Buy | 56% Buy | 56% Buy | 64% Buy |
| Last Month's Opinion | 8% Buy | 64% Buy | 100% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.48% since 04/02/26 | +0.27% since 04/02/26 | +0.89% since 04/02/26 | -0.52% since 04/02/26 | -1.64% since 04/02/26 |
| Low | 67.94 on 04/07/26 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 73.33 on 04/10/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 59.80 on 04/10/26 |
| 1-Month | |||||
| %Chg | -0.63% since 03/10/26 | +4.64% since 03/10/26 | -6.50% since 03/10/26 | -6.44% since 03/10/26 | -2.51% since 03/10/26 |
| Low | 61.51 on 03/24/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 73.33 on 04/10/26 | 207.30 on 04/10/26 | 380.14 on 03/11/26 | 149.30 on 03/11/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -5.61% since 01/09/26 | +7.78% since 01/09/26 | +7.64% since 01/09/26 | +14.77% since 01/09/26 | +4.94% since 01/09/26 |
| Low | 60.54 on 02/13/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 80.00 on 02/24/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +3.45% since 10/10/25 | +20.68% since 10/10/25 | +20.99% since 10/10/25 | +18.61% since 10/10/25 | +33.35% since 10/10/25 |
| Low | 60.54 on 02/13/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 85.25 on 12/09/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,087,935 | 316,431,744 | 189,440,224 | 172,517,456 | 119,686,496 |
| Shares Outstanding, K | 42,557 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 451,360,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -66,420,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 151,670,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -8,370,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.63 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 02/23/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/07/26 | 05/05/26 | 04/30/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.38 | 16.27 | 17.43 | 9.67 |